A phase II study of OSI-027 (ASP7486) for the treatment of Lymphatic Malformations
Latest Information Update: 03 Apr 2020
At a glance
- Drugs AVTX 006 (Primary)
- Indications Congenital abnormalities; Lymphatic disorders
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2020 According to a Cerecor media release, the Aevi Genomic Medicine has been acquired and merged with the Cerecor.
- 18 Jul 2019 New trial record